Home > Healthcare > Healthcare IT > Surveillance Solutions > Pharmacovigilance and Drug Safety Software Market

Pharmacovigilance and Drug Safety Software Market Share

Report ID: GMI6282
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Pharmacovigilance & Drug Safety Software Market Share

Major market players operating in the pharmacovigilance and drug safety software market include :

Arisglobal
AB Cube S.A.S.
Extedo GMBH
Ennov Solutions Inc.
United BioSource Corporation
Oracle Corporation,
Online Business
Applications Inc.
Sarjen Systems Pvt. Ltd
United Biosource Corporation
Genepact
Umbra Global among others.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Pharmacovigilance and drug safety software market size was USD 171.7 million in 2022 and will register USD 319.9 million by end of 2032 due to the rising number of adverse drug reactions (ADRs) and the presence of stringent guidelines by government and regulatory bodies.

The on-demand/cloud-based (SaaS) mode of delivery segment held 56.7% share of the market in 2022 owing to the surging need for enhanced accessibility, seamless scalability, and reduced infrastructure costs.

North America held 37.4% of the pharmacovigilance and drug safety software market share in 2022 owing to the surging demand for efficient and reliable drug safety solutions worldwide.

Arisglobal, AB Cube S.A.S., Extedo GMBH, Ennov Solutions Inc., United BioSource Corporation, Oracle Corporation, Online Business, Applications Inc., United Biosource Corporation, Genepact, and Umbra Global are some of the major pharmacovigilance and drug safety software industry players.